Indrayani Biotech Ltd — Important, 01-10-2025: Company Update

Indrayani Biotech's Annual General Meeting approved significant governance and strategic moves. Shareholders adopted the financial statements for the year ended March 31, 2025, and sanctioned the reappointment and appointment of several directors, bolstering leadership. A key decision involved increasing the authorized share capital to Rs. 85 Crore, providing capital flexibility. Crucially, the company received approval for disinvestment from Dindigul Farm Product Limited, a major subsidiary which contributed Rs. 62.83 Cr to consolidated turnover and Rs. 35.21 Cr to net worth last year, indicating a pivotal business restructuring.